Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.37% vs 10.02% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 16.22% vs 24.02% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.16% vs 70.51% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -80.00% vs 150.00% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

29.34

13.28

16.06

120.93%

Other Operating Income

0.00

Total Operating income

29.34

13.28

16.06

120.93%

Raw Material Cost

12.12

9.49

2.63

27.71%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.27

0.00

0.27

Employee Cost

1.41

1.40

0.01

0.71%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

9.48

2.03

7.45

367.00%

Total Expenditure (Excl Depreciation)

23.28

12.92

10.36

80.19%

Operating Profit (PBDIT) excl Other Income

6.06

0.36

5.70

1,583.33%

Other Income

1.33

0.55

0.78

141.82%

Operating Profit (PBDIT)

7.39

0.91

6.48

712.09%

Interest

0.01

0.16

-0.15

-93.75%

Exceptional Items

0.00

Gross Profit (PBDT)

7.38

0.75

6.63

884.00%

Depreciation

0.93

0.23

0.70

304.35%

Profit Before Tax

6.44

0.52

5.92

1,138.46%

Tax

1.64

0.18

1.46

811.11%

Provisions and contingencies

0.00

Profit After Tax

4.80

0.34

4.46

1,311.76%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

4.80

0.34

4.46

1,311.76%

Equity Capital

12.30

10.24

2.06

20.12%

Face Value

10.00

2.00

0.00

Reserves

98.83

0.00

98.83

Earnings per share (EPS)

3.90

0.07

3.83

5,471.43%

Diluted Earnings per share

3.90

0.07

3.83

5,471.43%

Operating Profit Margin (Excl OI)

20.65%

2.71%

0.00

17.94%

Gross Profit Margin

25.15%

5.65%

0.00

19.50%

PAT Margin

16.36%

2.56%

0.00

13.80%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 29.34 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 2.37% vs 10.02% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 37.23% vs -10.92% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 4.80 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 16.22% vs 24.02% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 727.59% vs -83.04% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 6.06 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -0.16% vs 70.51% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 326.76% vs -72.85% in Dec 2024

Quarterly - Interest

Interest 0.01 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -80.00% vs 150.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.65%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024